• About Us
  • Advertise
  • Contact Us
  • DMCA
  • Follow on Google News
Saturday, November 21, 2026
  • Login
News Mirror
  • Home
  • India
    • National
    • State News
  • World
  • Business
  • Education
  • Entertainment
  • Lifestyle
    • Health & Fitness
    • Fashion & Beauty
    • Travel
    • Food
    • Photography
  • Finance/Money
  • Tech
    • App News
    • Gadgets
  • Auto
  • Others
    • Sports
    • Agriculture
    • Science
    • Astrology
    • Press Release
    • Religion
    • Social Work
No Result
View All Result
  • Home
  • India
    • National
    • State News
  • World
  • Business
  • Education
  • Entertainment
  • Lifestyle
    • Health & Fitness
    • Fashion & Beauty
    • Travel
    • Food
    • Photography
  • Finance/Money
  • Tech
    • App News
    • Gadgets
  • Auto
  • Others
    • Sports
    • Agriculture
    • Science
    • Astrology
    • Press Release
    • Religion
    • Social Work
No Result
View All Result
News Mirror
No Result
View All Result
Home Lifestyle Health & Fitness

First mRNA-based COVID 19 vaccine gets nod for phase II/III trial

News Mirror by News Mirror
August 25, 2021
in Health & Fitness, National
Share on FacebookShare on Twitter

New Delhi: The fight against the ongoing epidemic of COVID-19 is all set to get stronger. The office of the Drug Controller General of India has approved a proposal of the Pune-based Gennova Biopharmaceuticals Ltd., to go in for phase II / III trial of the country’s first mRNA-based vaccine for COVID-19 called HGCO19.

The company had submitted the interim clinical data of the Phase I study to the Central Drugs Standard Control Organisation (CDSCO), the Government of India’s National Regulatory Authority (NRA). The Vaccine Subject Expert Committee (SEC) reviewed the data and found that the vaccine was safe, tolerable, and immunogenic in the participants of the study.

RelatedPosts

Lincoln Pharmaceuticals’ Namcold Oxy Brings “Khulke Saans Lo” to India’s Nasal Relief Market

Pionomed Biogenix Is Reimagining Reconstructive Surgery and Cancer Diagnosis Through Clinician-Led Innovation

Consequently, the proposal for Phase II and Phase III study for “A prospective, multicentre, randomized, active-controlled, observer-blind, phase II study seamlessly followed by a phase III study to evaluate the safety, tolerability, and immunogenicity of the candidate HGCO19 (covid-19 vaccine) in healthy subjects” was submitted that has now been approved.

The study will be conducted within India in 10-15 sites in Phase II and 22-27 sites in Phase III. Gennova plans to use the DBT-ICMR clinical trial network sites for this study.

The vaccine development program was partly funded by the Department of Biotechnology (DBT), Govt. of India under Ind CEPI, in June 2020. Later on, the DBT further supported the program under the Mission COVID Suraksha – The Indian COVID-19 Vaccine Development Mission, implemented by BIRAC.

“It is a matter of great pride that Nation’s first mRNA-based vaccine is found to be safe and the Drugs Controller General of India DCG(I) has approved Phase II/III trial. We are confident that this will be an important vaccine for both India and the world. This is an important milestone in our Indigenous Vaccine Development Mission and positions India on the Global Map for Novel Vaccine Development,” said Dr.RenuSwarup, Secretary, DBT, and Chairperson, Biotechnology Industry Research Assistance Council (BIRAC).

Dr. Sanjay Singh, CEO of Gennova Biopharmaceuticals Ltd., said that “After establishing the safety of our mRNA-based COVID-19 vaccine candidate HGCO19 in Phase I clinical trial, Gennova’s focus is to start Phase II/III pivotal clinical trial. In parallel, Gennova is investing in scaling up its manufacturing capacity to cater to the nation’s vaccine requirement”. (India Science Wire)

Tags: CDSCOCentral Drugs Standard Control OrganisationCOVID SurakshaDBTDCG (I)Department of BiotechnologyDrug Controller General of IndiaGennova Biopharmaceuticals Ltd.immunogenicityInd CEPImRNAPunesafetytolerabilityvaccine
Previous Post

Ogo Nirupama actress Arkoja Acharyya celebrates Rakshabandhan with renowned singer and producer Sarbajit Ghosh through upcoming calendar photoshoot

Next Post

Government incentive in offing for 75 start-ups in telemedicine, artificial intelligence, and digital health

Related Posts

Lincoln Pharmaceuticals’ Namcold Oxy Brings “Khulke Saans Lo” to India’s Nasal Relief Market
Health & Fitness

Lincoln Pharmaceuticals’ Namcold Oxy Brings “Khulke Saans Lo” to India’s Nasal Relief Market

October 19, 2026
Pionomed Biogenix Is Reimagining Reconstructive Surgery and Cancer Diagnosis Through Clinician-Led Innovation
Health & Fitness

Pionomed Biogenix Is Reimagining Reconstructive Surgery and Cancer Diagnosis Through Clinician-Led Innovation

September 28, 2026
SPARSH Hospitals Launches Two Digital Rehabilitation Initiatives to Extend Expert Care Beyond the Hospital.
Health & Fitness

SPARSH Hospitals Launches Two Digital Rehabilitation Initiatives to Extend Expert Care Beyond the Hospital.

September 12, 2026
Beyond Specialities: How Asha Multispeciality Hospital Is Building a More Connected Healthcare Experience in Malad
Health & Fitness

Beyond Specialities: How Asha Multispeciality Hospital Is Building a More Connected Healthcare Experience in Malad

September 10, 2026
Can You Trust AI with Your Dental Problems? Dentist Explains What AI Can and Cannot Do
Health & Fitness

Can You Trust AI with Your Dental Problems? Dentist Explains What AI Can and Cannot Do

August 25, 2026
Heart Attacks Among Men 35+ Are Becoming the Norm, Not the Exception, Warns Dr. Kiran Narang
Health & Fitness

Heart Attacks Among Men 35+ Are Becoming the Norm, Not the Exception, Warns Dr. Kiran Narang

August 7, 2026
Next Post

Government incentive in offing for 75 start-ups in telemedicine, artificial intelligence, and digital health

Niti Vakharia Kharwar from Nits saloon was honoured by One Step Charitable Trust as “Real Heroes of Surat”

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recommended.

How to Choose the Best Rehabilitation Centre in India?

January 17, 2022
Curatal ushers in curated talent – An idea whose time is now!

Curatal ushers in curated talent – An idea whose time is now!

November 29, 2022

Trending.

Neskeb Cables Draws on 25 Years of Industry Experience to Serve India’s Industrial Needs

Neskeb Cables Draws on 25 Years of Industry Experience to Serve India’s Industrial Needs

November 10, 2026
Add24 Takes Patna Marathon – The Odyssey 2026 Forward With a Run for a Drug-Free Bihar

Add24 Takes Patna Marathon – The Odyssey 2026 Forward With a Run for a Drug-Free Bihar

November 4, 2026
ACOHI – Asian Countries Chamber of Hospitality Industry Recognized by Union Minister Government of India Dr. Mansukh Mandaviya for Uplifting Grassroots Hospitality Workforce – Lady Housekeepers of Pune 

ACOHI – Asian Countries Chamber of Hospitality Industry Recognized by Union Minister Government of India Dr. Mansukh Mandaviya for Uplifting Grassroots Hospitality Workforce – Lady Housekeepers of Pune 

November 14, 2026
Make Every Moment Count: Gift More Possibilities with Kingston This Diwali

Make Every Moment Count: Gift More Possibilities with Kingston This Diwali

November 18, 2026

TECNO launches SPARK Power 2 Air: The new Power Play Entertainment device

September 14, 2020
News Mirror

© 2022 News Mirror

  • About Us
  • Advertise
  • Contact Us
  • DMCA
  • Follow on Google News

Follow Us

No Result
View All Result
  • About Us
  • Advertise
  • Contact Us
  • DMCA
  • Home
  • Privacy Policy

© 2022 News Mirror

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In